QSAR in Development of Antidepressants
QSAR in Development of Antidepressants
QSAR in Development of Antidepressants
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
References<br />
• Phil Skolnick, P. P., Aaron Janowsky, Bernard Beer, Arnold S. Lippa<br />
Antidepressant-like actions <strong>of</strong> DOV 21,947: a "triple" reuptake <strong>in</strong>hibitor.<br />
European journal <strong>of</strong> pharmacology. 2003, 461, 99-104.<br />
• Kamal, A., et. al Chemoenzymatic synthesis <strong>of</strong> duloxet<strong>in</strong>e and its<br />
enantiomer liase-catalyzed resolution <strong>of</strong> 3hydroxy-3-(2-thienyl)<br />
propanenitrile. Tetrahedron letters 2003, 44, 4783-4787<br />
• Frazer, A. <strong>Antidepressants</strong>. Journal <strong>of</strong> Cl<strong>in</strong>ical Psychiatry 1997, 58, 9-25.<br />
• Schafer, W. R. Do <strong>Antidepressants</strong> Work? Prospects for Genetic Analysis <strong>of</strong><br />
Drug Mechanisms. Cell 1999, 98, 551-554.<br />
• Evrard, D., P<strong>in</strong>g Zhou, Soo i, Dahui Zhou, Deborah L. Smith, Kelly M.<br />
Sullivan, Ge<strong>of</strong>frey A. Hornby, lee E. Schechter, Terrance H. Andree, and<br />
Richard E. Mewshaw Studies towards the next generation <strong>of</strong><br />
antidepressants. Part 4: Derivatives <strong>of</strong> 4-(5fluoro-1H-<strong>in</strong>dol-3-<br />
yl)cyclohexylam<strong>in</strong>e with aff<strong>in</strong>ity for the seroton<strong>in</strong> transporter and the 5-HT1A<br />
receptor. Bioorganic & Medic<strong>in</strong>al Chemistry Letters 2005, 15, 911-914.<br />
• Owens, M. Selectivity <strong>of</strong> <strong>Antidepressants</strong> from Monoam<strong>in</strong>e Hypothesis <strong>of</strong><br />
Depression to the SSRI Revolution and Beyond. Journal <strong>of</strong> Cl<strong>in</strong>ical<br />
Psychiatry 2004, 65, 5-10.
Change language